BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33893322)

  • 1. Genetic interactions among Brca1, Brca2, Palb2, and Trp53 in mammary tumor development.
    Huo Y; Selenica P; Mahdi AH; Pareja F; Kyker-Snowman K; Chen Y; Kumar R; Da Cruz Paula A; Basili T; Brown DN; Pei X; Riaz N; Tan Y; Huang YX; Li T; Barnard NJ; Reis-Filho JS; Weigelt B; Xia B
    NPJ Breast Cancer; 2021 Apr; 7(1):45. PubMed ID: 33893322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the BRCA1-PALB2 interaction accelerates p53-associated tumor development in mice.
    Mahdi AH; Huo Y; Chen Y; Selenica P; Sharma A; Merritt E; Barnard N; Chan C; Ganesan S; Reis-Filho JS; Weigelt B; De S; Xia B
    Genes Dis; 2022 May; 9(3):807-813. PubMed ID: 35782971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
    Bowman-Colin C; Xia B; Bunting S; Klijn C; Drost R; Bouwman P; Fineman L; Chen X; Culhane AC; Cai H; Rodig SJ; Bronson RT; Jonkers J; Nussenzweig A; Kanellopoulou C; Livingston DM
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8632-7. PubMed ID: 23657012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A BRCA1 Coiled-Coil Domain Variant Disrupting PALB2 Interaction Promotes the Development of Mammary Tumors and Confers a Targetable Defect in Homologous Recombination Repair.
    Pulver EM; Mukherjee C; van de Kamp G; Roobol SJ; Rother MB; van der Gulden H; de Bruijn R; Lattanzio MV; van der Burg E; Drenth AP; Verkaik NS; Hahn K; Klarenbeek S; de Korte-Grimmerink R; van de Ven M; Pritchard CEJ; Huijbers IJ; Xia B; van Gent DC; Essers J; van Attikum H; Ray Chaudhuri A; Bouwman P; Jonkers J
    Cancer Res; 2021 Dec; 81(24):6171-6182. PubMed ID: 34548335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine models for familial pancreatic cancer: Histopathology, latency and drug sensitivity among cancers of Palb2, Brca1 and Brca2 mutant mouse strains.
    Park D; Shakya R; Koivisto C; Pitarresi JR; Szabolcs M; Kladney R; Hadjis A; Mace TA; Ludwig T
    PLoS One; 2019; 14(12):e0226714. PubMed ID: 31877165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer.
    Huo Y; Cai H; Teplova I; Bowman-Colin C; Chen G; Price S; Barnard N; Ganesan S; Karantza V; White E; Xia B
    Cancer Discov; 2013 Aug; 3(8):894-907. PubMed ID: 23650262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene.
    Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L
    Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-exome DNA sequence analysis of Brca2- and Trp53-deficient mouse mammary gland tumours.
    Francis JC; Melchor L; Campbell J; Kendrick H; Wei W; Armisen-Garrido J; Assiotis I; Chen L; Kozarewa I; Fenwick K; Swain A; Smalley MJ; Lord CJ; Ashworth A
    J Pathol; 2015 Jun; 236(2):186-200. PubMed ID: 25692405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compromised BRCA1-PALB2 interaction is associated with breast cancer risk.
    Foo TK; Tischkowitz M; Simhadri S; Boshari T; Zayed N; Burke KA; Berman SH; Blecua P; Riaz N; Huo Y; Ding YC; Neuhausen SL; Weigelt B; Reis-Filho JS; Foulkes WD; Xia B
    Oncogene; 2017 Jul; 36(29):4161-4170. PubMed ID: 28319063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2.
    Zhang F; Fan Q; Ren K; Andreassen PR
    Mol Cancer Res; 2009 Jul; 7(7):1110-8. PubMed ID: 19584259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Double PALB2 and BRCA1/BRCA2 mutation carriers are rare in breast cancer and breast-ovarian cancer syndrome families from the French Canadian founder population.
    Ancot F; Arcand SL; Mes-Masson AM; Provencher DM; Tonin PN
    Oncol Lett; 2015 Jun; 9(6):2787-2790. PubMed ID: 26137147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PALB2 links BRCA1 and BRCA2 in the DNA-damage response.
    Zhang F; Ma J; Wu J; Ye L; Cai H; Xia B; Yu X
    Curr Biol; 2009 Mar; 19(6):524-9. PubMed ID: 19268590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Compensatory functions and interdependency of the DNA-binding domain of BRCA2 with the BRCA1-PALB2-BRCA2 complex.
    Al Abo M; Dejsuphong D; Hirota K; Yonetani Y; Yamazoe M; Kurumizaka H; Takeda S
    Cancer Res; 2014 Feb; 74(3):797-807. PubMed ID: 24285729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent mutations of BRCA1, BRCA2 and PALB2 in the population of breast and ovarian cancer patients in Southern Poland.
    Wojcik P; Jasiowka M; Strycharz E; Sobol M; Hodorowicz-Zaniewska D; Skotnicki P; Byrski T; Blecharz P; Marczyk E; Cedrych I; Jakubowicz J; Lubiński J; Sopik V; Narod S; Pierzchalski P
    Hered Cancer Clin Pract; 2016; 14():5. PubMed ID: 26843898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PALB2 is an integral component of the BRCA complex required for homologous recombination repair.
    Sy SM; Huen MS; Chen J
    Proc Natl Acad Sci U S A; 2009 Apr; 106(17):7155-60. PubMed ID: 19369211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of Intertissue Differences in the DNA Damage Response and the Pro-oncogenic Role of NF-κB in Mice with Disengaged BRCA1-PALB2 Interaction.
    Mahdi AH; Huo Y; Tan Y; Simhadri S; Vincelli G; Gao J; Ganesan S; Xia B
    Cancer Res; 2018 Jul; 78(14):3969-3981. PubMed ID: 29739757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer.
    Downs B; Kim YC; Xiao F; Snyder C; Chen P; Fleissner EA; Becirovic D; Wen H; Sherman S; Cowan KH; Lynch HT; Wang SM
    Breast Cancer Res Treat; 2015 May; 151(1):219-24. PubMed ID: 25833210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coiled-Coil Domain: Uncoiling Tumor Suppression by BRCA1.
    Mishra AP; Sahu S; Sharan SK
    Cancer Res; 2021 Dec; 81(24):6080-6082. PubMed ID: 34911781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of PALB2 gene in BRCA1/BRCA2 negative Spanish hereditary breast/ovarian cancer families with pancreatic cancer cases.
    Blanco A; de la Hoya M; Osorio A; Diez O; Miramar MD; Infante M; Martinez-Bouzas C; Torres A; Lasa A; Llort G; Brunet J; Graña B; Perez Segura P; Garcia MJ; Gutiérrez-Enríquez S; Carracedo Á; Tejada MI; Velasco EA; Calvo MT; Balmaña J; Benitez J; Caldés T; Vega A
    PLoS One; 2013; 8(7):e67538. PubMed ID: 23935836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer.
    Casadei S; Norquist BM; Walsh T; Stray S; Mandell JB; Lee MK; Stamatoyannopoulos JA; King MC
    Cancer Res; 2011 Mar; 71(6):2222-9. PubMed ID: 21285249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.